Cerebral vasodilators.
D000368:Aged; D000438:Alcohols / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000008:administration & dosage; D002539:Cerebral Arterial Diseases / Q000188:drug therapy; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003510:Cyclohexanes / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D002546:Ischemic Attack, Transient / Q000139:chemically induced / Q000188:drug therapy; D008333:Mandelic Acids / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012138:Respiratory Therapy; D013345:Subarachnoid Hemorrhage / Q000150:complications; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D000438:Alcohols; D003510:Cyclohexanes; D008333:Mandelic Acids; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D002245:Carbon Dioxide; D010208:Papaverine